2
|
Gopinath PM, Darekar AS, Kanimozhi S, Mukherjee A, Chandrasekaran N. Female mosquito-a potential vector for transporting plastic residues to humans. CHEMOSPHERE 2022; 301:134666. [PMID: 35452648 DOI: 10.1016/j.chemosphere.2022.134666] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/28/2021] [Revised: 04/02/2022] [Accepted: 04/17/2022] [Indexed: 06/14/2023]
Abstract
With the prodigious use of plastics in the industrial sector and daily life, plastic has become one of the fastest-growing sources of pollution in the aquatic environment. Therefore, ingestion of micro/nanoplastics (MP/NPs) by aquatic organisms is inevitable. But the knowledge on the definite effect, ontogenetic transfer, and translocation of NPs remains incipient. Thus, this study examines the abundance of MPs in mosquito larvae collected from the sewage pit. Additionally, this study demonstrates the MPs-mediated biochemical alterations and effects on development of mosquito, and then ontogenetic transfer and translocation of NPs in Aedes aegypti. Totally 1241 MPs belonging to polyethylene, polycarbonate, polypropylene, polystyrene, polyvinyl chloride and nylon with sizes ranging from 0.5 μm to 80 μm in diameter were isolated from the mosquito larvae. Indeed all the four stages of mosquito larvae feed on NPs and subsequently transfer them to non-feeding pupa and then to flying adult mosquitoes, further to the offspring. However, the NPs exposure and accumulation did not affect the survival of mosquitoes, but altered the biochemical constituents, thereby delaying the development of mosquitoes. Notably the female mosquitoes that emerged from the NPs treatment group showed increased blood-feeding activity and increased starvation resistance capacity. The puzzling accumulation of NPs/residues in different organs, especially in the salivary gland signifies that female mosquitoes could potentially inject polymer residues into humans and animals. At the outset, these observations emphasize that the mosquitoes act as a vector of NPs in the aqueous environment and transport them to terrestrial animals.
Collapse
Affiliation(s)
| | - Ankita Shivaji Darekar
- Centre for Nanobiotechnology, Vellore Institute of Technology (VIT), Vellore, 632 014, Tamil Nadu, India
| | - Subramanian Kanimozhi
- Centre for Nanobiotechnology, Vellore Institute of Technology (VIT), Vellore, 632 014, Tamil Nadu, India
| | - Amitava Mukherjee
- Centre for Nanobiotechnology, Vellore Institute of Technology (VIT), Vellore, 632 014, Tamil Nadu, India
| | - Natarajan Chandrasekaran
- Centre for Nanobiotechnology, Vellore Institute of Technology (VIT), Vellore, 632 014, Tamil Nadu, India.
| |
Collapse
|
3
|
Adam A, Fontes-Garfias CR, Sarathy VV, Liu Y, Luo H, Davis E, Li W, Muruato AE, Wang B, Ahatov R, Mahmoud Y, Shan C, Osman SR, Widen SG, Barrett ADT, Shi PY, Wang T. A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmission. NPJ Vaccines 2021; 6:27. [PMID: 33597526 PMCID: PMC7889622 DOI: 10.1038/s41541-021-00288-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2020] [Accepted: 01/15/2021] [Indexed: 12/20/2022] Open
Abstract
Although live attenuated vaccines (LAVs) have been effective in the control of flavivirus infections, to date they have been excluded from Zika virus (ZIKV) vaccine trials due to safety concerns. We have previously reported two ZIKV mutants, each of which has a single substitution in either envelope (E) glycosylation or nonstructural (NS) 4B P36 and displays a modest reduction in mouse neurovirulence and neuroinvasiveness, respectively. Here, we generated a ZIKV mutant, ZE4B-36, which combines mutations in both E glycosylation and NS4B P36. The ZE4B-36 mutant is stable and attenuated in viral replication. Next-generation sequence analysis showed that the attenuating mutations in the E and NS4B proteins are retained during serial cell culture passages. The mutant exhibits a significant reduction in neuroinvasiveness and neurovirulence and low infectivity in mosquitoes. It induces robust ZIKV-specific memory B cell, antibody, and T cell-mediated immune responses in type I interferon receptor (IFNR) deficient mice. ZIKV-specific T cell immunity remains strong months post-vaccination in wild-type C57BL/6 (B6) mice. Vaccination with ZE4B-36 protects mice from ZIKV-induced diseases and vertical transmission. Our results suggest that combination mutations in E glycosylation and NS4B P36 contribute to a candidate LAV with significantly increased safety but retain strong immunogenicity for prevention and control of ZIKV infection.
Collapse
Affiliation(s)
- Awadalkareem Adam
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA
| | - Camila R Fontes-Garfias
- Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA
| | - Vanessa V Sarathy
- Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA
- Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA
| | - Yang Liu
- Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA
| | - Huanle Luo
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA
| | - Emily Davis
- Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA
| | - Wenqian Li
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA
| | - Antonio E Muruato
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA
- Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA
| | - Binbin Wang
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA
| | - Renat Ahatov
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA
| | - Yoseph Mahmoud
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA
| | - Chao Shan
- Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA
| | - Samantha R Osman
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA
| | - Steven G Widen
- Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA
- Molecular Genomics Core Facility, University of Texas Medical Branch, Galveston, TX, USA
| | - Alan D T Barrett
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA
- Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA
- Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA
| | - Pei-Yong Shi
- Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
- Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA.
- Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA.
| | - Tian Wang
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA.
- Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
- Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA.
| |
Collapse
|